Cargando…
Vaccine development for emerging virulent infectious diseases
The recent outbreak of Zaire Ebola virus in West Africa altered the classical paradigm of vaccine development and that for emerging infectious diseases (EIDs) in general. In this paper, the precepts of vaccine discovery and advancement through pre-clinical and clinical assessment are discussed in th...
Autor principal: | Maslow, Joel N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115543/ https://www.ncbi.nlm.nih.gov/pubmed/28216184 http://dx.doi.org/10.1016/j.vaccine.2017.02.015 |
Ejemplares similares
-
The cost and challenge of vaccine development for emerging and emergent infectious diseases
por: Maslow, Joel N
Publicado: (2018) -
Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus
por: Maslow, Joel N.
Publicado: (2017) -
Assay Challenges for Emerging Infectious Diseases: The Zika Experience
por: Roberts, Christine C., et al.
Publicado: (2018) -
Zika Vaccine Development—Current Progress and Challenges for the Future
por: Maslow, Joel N.
Publicado: (2019) -
Rapid response to an emerging infectious disease – Lessons learned from development of a synthetic DNA vaccine targeting Zika virus
por: Kudchodkar, Sagar B., et al.
Publicado: (2018)